Literature DB >> 20737575

Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.

Jianjun Zhang1, Haiyan Guo, He Zhang, Haibo Wang, Guanxiang Qian, Xianqun Fan, Andrew R Hoffman, Ji-Fan Hu, Shengfang Ge.   

Abstract

BACKGROUND: Tumor suppressor microRNA miR-145 is commonly down-regulated in colon carcinoma tissues, but its specific role in tumors remains unknown.
METHODS: In this study, the authors identified the Friend leukemia virus integration 1 gene (FLI1) as a novel target of miR-145. FLI1 is involved in t(11;22)(q24:q12) reciprocal chromosomal translocation in Ewing sarcoma, and its expression appears to be associated with biologically more aggressive tumors.
RESULTS: The authors demonstrated that miR-145 targets a putative microRNA regulatory element in the 3'-untranslated region (UTR) of FLI1, and its abundance is reversely associated with FLI1 expression in colon cancer tissues and cell lines. By using a luciferase/FLI1 3'-UTR reporter system, they found that miR-145 down-regulated the reporter activity, and this down-regulation was reversed by anti-miR-145. Mutation of the miR-145 microRNA regulatory element sequence in the FLI1 3'-UTR abolished the activity of miR-145. miR-145 decreased FLI1 protein but not FLI1 mRNA, suggesting a mechanism of translational regulation. Furthermore, the authors demonstrated that miR-145 inhibited cell proliferation and sensitized LS174T cells to 5-fluorouracil-induced apoptosis.
CONCLUSIONS: Taken together, these results suggest that miR-145 functions as a tumor suppressor by down-regulating oncogenic FLI1 in colon cancer.
© 2010 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20737575      PMCID: PMC2995010          DOI: 10.1002/cncr.25522

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  48 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke.

Authors:  Alberto Izzotti; George A Calin; Patrizio Arrigo; Vernon E Steele; Carlo M Croce; Silvio De Flora
Journal:  FASEB J       Date:  2008-10-24       Impact factor: 5.191

Review 3.  The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action.

Authors:  M F White
Journal:  Recent Prog Horm Res       Date:  1998

4.  FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.

Authors:  R Pereira; C T Quang; I Lesault; H Dolznig; H Beug; J Ghysdael
Journal:  Oncogene       Date:  1999-02-25       Impact factor: 9.867

5.  Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.

Authors:  William C S Cho; Andrew S C Chow; Joseph S K Au
Journal:  Eur J Cancer       Date:  2009-06-01       Impact factor: 9.162

6.  Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway.

Authors:  Gaspare La Rocca; Margherita Badin; Bin Shi; Shi-Qiong Xu; Tiziana Deangelis; Laura Sepp-Lorenzinoi; Renato Baserga
Journal:  J Cell Physiol       Date:  2009-08       Impact factor: 6.384

7.  p53 represses c-Myc through induction of the tumor suppressor miR-145.

Authors:  Mohit Sachdeva; Shoumin Zhu; Fangting Wu; Hailong Wu; Vijay Walia; Sumit Kumar; Randolph Elble; Kounosuke Watabe; Yin-Yuan Mo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

Review 8.  MicroRNAs and cancer.

Authors:  Jack B Cowland; Christoffer Hother; Kirsten Grønbaek
Journal:  APMIS       Date:  2007-10       Impact factor: 3.205

9.  Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.

Authors:  Lorenzo F Sempere; Mette Christensen; Asli Silahtaroglu; Mads Bak; Catherine V Heath; Gary Schwartz; Wendy Wells; Sakari Kauppinen; Charles N Cole
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

Review 10.  OncomiRs: the discovery and progress of microRNAs in cancers.

Authors:  William C S Cho
Journal:  Mol Cancer       Date:  2007-09-25       Impact factor: 27.401

View more
  62 in total

Review 1.  The role of microRNAs in colorectal cancer.

Authors:  Aaron J Schetter; Hirokazu Okayama; Curtis C Harris
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

Review 2.  Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.

Authors:  Timothy Ming-Hun Wan; Deepak Narayanan Iyer; Lui Ng
Journal:  Histol Histopathol       Date:  2019-10-16       Impact factor: 2.303

3.  lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.

Authors:  Gabriel Eades; Benjamin Wolfson; Yongshu Zhang; Qinglin Li; Yuan Yao; Qun Zhou
Journal:  Mol Cancer Res       Date:  2014-09-24       Impact factor: 5.852

4.  Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia.

Authors:  Steven M Kornblau; Yi Hua Qiu; Nianxiang Zhang; Neera Singh; Stefan Faderl; Alessandra Ferrajoli; Heather York; Amina A Qutub; Kevin R Coombes; Dennis K Watson
Journal:  Blood       Date:  2011-09-13       Impact factor: 22.113

Review 5.  Cancer stem cells in colorectal cancer and the association with chemotherapy resistance.

Authors:  Xue Lei; Qinglian He; Ziqi Li; Qian Zou; Pingrong Xu; Haibing Yu; Yuanlin Ding; Wei Zhu
Journal:  Med Oncol       Date:  2021-03-18       Impact factor: 3.064

6.  Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome.

Authors:  Kerry M Bauer; Amanda B Hummon
Journal:  J Proteome Res       Date:  2012-08-27       Impact factor: 4.466

7.  miR-145a Regulation of Pericyte Dysfunction in a Murine Model of Sepsis.

Authors:  Yan Wu; Pengfei Li; Andrew J Goodwin; James A Cook; Perry V Halushka; Basilia Zingarelli; Hongkuan Fan
Journal:  J Infect Dis       Date:  2020-08-17       Impact factor: 5.226

8.  Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer.

Authors:  Rui-Lei Liu; Ye Dong; Yan-Zhen Deng; Wen-Jun Wang; Wei-Dong Li
Journal:  Tumour Biol       Date:  2015-04-27

9.  Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma.

Authors:  Danira Ashraf Habashy; Hend Mohamed El Tayebi; Injie Omar Fawzy; Karim Adel Hosny; Gamal Esmat; Ahmed Ihab Abdelaziz
Journal:  World J Hepatol       Date:  2016-08-18

Review 10.  Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

Authors:  Yoshinaga Okugawa; William M Grady; Ajay Goel
Journal:  Gastroenterology       Date:  2015-07-26       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.